The 5 analysts offering 12-month price forecasts for 10X Genomics Inc have a median target of 80.00, with a high estimate of 100.00 and a low estimate of 64.00. The median estimate represents a -20.63% decrease from the last price of 100.79.
The current consensus among 5 polled investment analysts is to Buy stock in 10X Genomics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date Feb 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.